Drug profile · INN
pamiparib
pamiparib is a poly [adp-ribose] polymerase 2 inhibitor.
NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — pamiparib
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.70
Quick answer
pamiparib is a poly [adp-ribose] polymerase 2 inhibitor.
Key facts
INN pamiparib
Mechanism Poly [ADP-ribose] polymerase 2 inhibitor
Target Poly [ADP-ribose] polymerase 2
Mechanism of action
Poly [ADP-ribose] polymerase 2 inhibitor
Primary target: Poly [ADP-ribose] polymerase 2
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is pamiparib?
pamiparib is a poly [adp-ribose] polymerase 2 inhibitor.